156 related articles for article (PubMed ID: 38308396)
41. High intravascular tissue factor expression in dogs with idiopathic immune-mediated haemolytic anaemia.
Piek CJ; Brinkhof B; Teske E; Rothuizen J; Dekker A; Penning LC
Vet Immunol Immunopathol; 2011 Dec; 144(3-4):346-54. PubMed ID: 21899896
[TBL] [Abstract][Full Text] [Related]
42. Good agreement of conventional and gel-based direct agglutination test in immune-mediated haemolytic anaemia.
Piek CJ; Teske E; van Leeuwen MW; Day MJ
Acta Vet Scand; 2012 Feb; 54(1):10. PubMed ID: 22316049
[TBL] [Abstract][Full Text] [Related]
43. Opportunistic Invasive Cutaneous Fungal Infections Associated with Administration of Cyclosporine to Dogs with Immune-mediated Disease.
McAtee BB; Cummings KJ; Cook AK; Lidbury JA; Heseltine JC; Willard MD
J Vet Intern Med; 2017 Nov; 31(6):1724-1729. PubMed ID: 28887897
[TBL] [Abstract][Full Text] [Related]
44. C
Goggs R; Behling-Kelly E
BMC Vet Res; 2019 Dec; 15(1):475. PubMed ID: 31888626
[TBL] [Abstract][Full Text] [Related]
45. The utility of screening diagnostic tests in identifying associative immune-mediated haemolytic anaemia in dogs.
Woodward GM; White JD
Aust Vet J; 2020 Dec; 98(12):586-590. PubMed ID: 32935334
[TBL] [Abstract][Full Text] [Related]
46. Immune-mediated hematological disease in dogs is associated with alterations of the fecal microbiota: a pilot study.
Liu PY; Xia D; McGonigle K; Carroll AB; Chiango J; Scavello H; Martins R; Mehta S; Krespan E; Lunde E; LeVine D; Fellman CL; Goggs R; Beiting DP; Garden OA
Anim Microbiome; 2023 Sep; 5(1):46. PubMed ID: 37770990
[TBL] [Abstract][Full Text] [Related]
47. Treatment of immune-mediated hemolytic anemia with individually adjusted heparin dosing in dogs.
Helmond SE; Polzin DJ; Armstrong PJ; Finke M; Smith SA
J Vet Intern Med; 2010; 24(3):597-605. PubMed ID: 20384956
[TBL] [Abstract][Full Text] [Related]
48. [Use of human intravenous immunoglobulin in dogs with primary immune mediated hemolytic anemia].
Gerber B; Steger A; Hässig M; Glaus TM
Schweiz Arch Tierheilkd; 2002 Apr; 144(4):180-5. PubMed ID: 12038216
[TBL] [Abstract][Full Text] [Related]
49. The utility of diagnostic tests for immune-mediated hemolytic anemia.
; MacNeill AL; Dandrieux J; Lubas G; Seelig D; Szladovits B
Vet Clin Pathol; 2019 Oct; 48 Suppl 1():7-16. PubMed ID: 31502273
[TBL] [Abstract][Full Text] [Related]
50. Antiphospholipid antibodies in dogs with immune mediated hemolytic anemia, spontaneous thrombosis, and hyperadrenocorticism.
Miller AG; Dow S; Long L; Olver CS
J Vet Intern Med; 2012; 26(3):614-23. PubMed ID: 22489954
[TBL] [Abstract][Full Text] [Related]
51. Detection of activated platelets in dogs with primary immune-mediated hemolytic anemia.
Weiss DJ; Brazzell JL
J Vet Intern Med; 2006; 20(3):682-6. PubMed ID: 16734108
[TBL] [Abstract][Full Text] [Related]
52. Serum biomarkers of clinical and cytologic response in dogs with idiopathic immune-mediated polyarthropathy.
Foster JD; Sample S; Kohler R; Watson K; Muir P; Trepanier LA
J Vet Intern Med; 2014; 28(3):905-11. PubMed ID: 24698600
[TBL] [Abstract][Full Text] [Related]
53. Use of serum concentrations of interleukin-18 and monocyte chemoattractant protein-1 as prognostic indicators in primary immune-mediated hemolytic anemia in dogs.
Kjelgaard-Hansen M; Goggs R; Wiinberg B; Chan DL
J Vet Intern Med; 2011; 25(1):76-82. PubMed ID: 21092010
[TBL] [Abstract][Full Text] [Related]
54. Comparison of cytokine responses between dogs with sepsis and dogs with immune-mediated hemolytic anemia.
Johnson V; Burgess B; Morley P; Bragg R; Avery A; Dow S
Vet Immunol Immunopathol; 2016 Nov; 180():15-20. PubMed ID: 27692090
[TBL] [Abstract][Full Text] [Related]
55. Cell-Free DNA and DNase Activity in Dogs with Immune-Mediated Hemolytic Anemia.
Jeffery U; Ruterbories L; Hanel R; LeVine DN
J Vet Intern Med; 2017 Sep; 31(5):1441-1450. PubMed ID: 28833583
[TBL] [Abstract][Full Text] [Related]
56. Canine immune-mediated hemolytic anemia: pathophysiology, clinical signs, and diagnosis.
Balch A; Mackin A
Compend Contin Educ Vet; 2007 Apr; 29(4):217-25. PubMed ID: 17726851
[TBL] [Abstract][Full Text] [Related]
57. [Evaluation of different prognostic markers in dogs with primary immune-mediated hemolytic anemia].
Griebsch C; Arndt G; Kohn B
Berl Munch Tierarztl Wochenschr; 2010; 123(3-4):160-8. PubMed ID: 20329649
[TBL] [Abstract][Full Text] [Related]
58. Canine immune-mediated polyarthritis: clinical and laboratory findings in 83 cases in western Canada (1991-2001).
Stull JW; Evason M; Carr AP; Waldner C
Can Vet J; 2008 Dec; 49(12):1195-203. PubMed ID: 19252711
[TBL] [Abstract][Full Text] [Related]
59. Primary immune-mediated haemolytic anaemia: a retrospective long-term study in 61 dogs.
Weingart C; Thielemann D; Kohn B
Aust Vet J; 2019 Dec; 97(12):483-489. PubMed ID: 31454853
[TBL] [Abstract][Full Text] [Related]
60. Demographic Characteristics, Survival and Prognostic Factors for Mortality in Cats with Primary Immune-Mediated Hemolytic Anemia.
Swann JW; Szladovits B; Glanemann B
J Vet Intern Med; 2016; 30(1):147-56. PubMed ID: 26645865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
